Dr Clifford Pang - Director
CEO and Hospital Director of the Clifford Hospital, Guangdong and CEO of the Clifford Medical Management Ltd., Guangzhou, China.
Dr Pang is a practising TCM MD and Professor at Clifford Hospital.
Dr Pang is a director of Biological Therapies.
Education and Proessional Experience
1959-1963
Indiana University, USA- Bachelor's Degree.
1963- 1965
McGill University, Canada- Master's Degree.
2006-2009
Jinan University School of Medicine — PhD Pathophysiology.
2000-2021
Chairman of the Board, President and CEO, Director of Clifford Hospital.
06/2003 to 08/2021
Director of Clifford Hospital.
1) Led weekly physician rounds and hospital administration.
2) Achieved JCI accreditation seven consecutive times (2003-2021).
3) Passed national "Grade 3A" Traditional Chinese Medicine hospital reviews (2008,2014).
4) Passed national "Grade 3A" Hospital of Integrated Traditional Chinese and Western Medicine reviews (2021).
5) Awarded "Guangdong Famous Hospital of Traditional Chinese Medicine"
(2009).
08/2021 — present
Lifetime Honorary Director of Clifford Hospital.
11/2001-02/2014
Guest Professor, Guangzhou University of Chinese Medicine.
05/2011-04/2014
Guest Professor, Beijing University of Chinese Medicine.
07/2010
Honorary Master's Supervisor, Guangzhou University of Chinese Medicine.
05/2012
Adjunct PhD Supervisor, Guangzhou University of Chinese Medicine.
2017
Board Member, Jinan University.
12/2012
Graduate Mentor, Jinan University School of Medicine.
Social Services, Awards and Honors
2005-2008
Member, 10th and 11th National Committee of the Chinese People's Political Consultative Conference (CPPCC).
12/2005-02/2014
Council Member, Standing Council Member, and Vice President, Guangdong Hospital Association (3 rd, 8th' 10th terms).
11/2006- 12/2008
Committee Member, Hepatocellular Carcinoma Division, Guangdong Liver Disease Association.
09/2007
Advisor, Overseas TCM Practitioner Registration Committee, China Association of Chinese Medicine.
11/2007
Deputy Director, 4th Committee of Oncology, Guangdong Association of Integrative Medicine.
12/2007
Deputy Director, 2nd Committee of TCM Psychology, Guangdong Association of Chinese Medicine.
12/2008
Honorary Advisor, Hong Kong Healthcare Association.
01/2008- 12/2010
Deputy Editor-in-Chief, Modern Hospitals Journal.
04/2008-04/2011
Vice President, Hospital Management Branch, China Association of Chinese Medicine.
04/2008
Director, Continuing Education Base, China Association of Chinese Medicine.
12/2008- 12/2013
Council Member, Guangdong Society of Pathophysiology.
01/2009
Standing Council Member, 4th Council of Guangzhou Anti-Cancer Association.
2008-2019
Individual Member, 1st Council of Chinese Hospital Association.
02/2009
Standing Council Member, 1st Council of Chinese Hospital Association.
08/2011
Council Member, 2 nd Council of Chinese Hospital Association.
12/2009-12/2013
Standing Council Member, 4th Council of China Medical Qigong Association.
01/2010 - 06/2013
President, Chinese TCM Practitioners Association Limited.
05/2011-11/2020
President, 1st and 2 nd Councils of Natural Therapy Research Committee, World Federation of Chinese Medicine Societies.
10/2012 - 10/2016
Editorial Board Member, 8th Committee of Journal of Guangzhou University of
Chinese Medicine.
2012
President, 32 nd Council of International Clinical Hyperthermia Society (ICHS). 2016
President, 35th Council of International Clinical Hyperthermia Society (ICHS).
01/2013 - 01/2017
Standing Committee Member, Hospital Scientific Management Committee, China Association for Promotion of TCM Research.
01/2013 - 12/2017
Vice President, 2 nd Council of Guangdong Health Care Association.
09/2014
Standing Council Member, 5th Council of China Medical Qigong Association.
11/2014
Standing Council Member, 6th Council of China Association of Chinese Medicine.
07/2015 - 07/2019
Vice President, 1st Council of Community Services Committee, World Federation of Chinese Medicine Societies.
07/2015
Committee Member, 1st TCM Expert Committee, People's Medical Publishing House.
06/2016 - 06/2020
Vice 1st Council of Cancer Palliative Care Research Committee, World Federation of Chinese Medicine Societies.
2016 - 2021
Standing Council Member, 7th Council of Guangdong Society of Pathophysiology.
08/2019 - 06/2024
President, Non-Public Medical Institutions Rehabilitation Branch, Guangdong Rehabilitation Medical Association.
2023 and 2003 — present
Honorary Advisor, Greater Bay Area Healthcare Professional Development Association.
2003
Philanthropist, New Great Wall Education Poverty Alleviation Project.
09/2003
Awarded "Contribution Award" by China Association of Chinese Medicine.
03/2005
Recipient of "2004 Special Contribution Award for China's Top 10 Hospital Brands".
09/2007
Named "Dutstanding President of National TCM Hospitals" by China Association of Chinese Medicine.
12/2008
Awarded "Top 100 Hospital Management Leaders in China" (for outstanding leadership over the past decade.
06/2009
Named "Top 10 Meritorious Figures in National Hospital Management".
02/2012
Awarded "Academic Excellence Award" by World Federation of Chinese Medicine Societies.
04/2012
Awarded "Contribution to Academic Development Award" by China Association of Chinese Medicine.
Medical Research & Publications
2000 — present
Founded Clifford Hospital's Natural Therapy Centre, China's first integrated natural medicine centre for treatment, education and research.
2000 - present
Pioneered "Green Comprehensive Therapy for Cancer", integrating TCM and
Western Medicine. His keynote speech at the 3 rd World Integrative Medicine Conference garnered significant acclaim. This therapy exemplifies successful integrative oncology and advances TCM globally, benefiting cancer patients worldwide.
2000 — present
Dedicated to TCM theory and clinical practice while promoting its global integration. Developed a novel detoxification therapy combining
chelation therapy, TCM and modern nutrition, achieving notable results in wellness and oncology.
2005
Led Guangdong TCM Bureau project: Effects of Natural Medicine Combined with Hyperthermia on Immune Function in Mid-to-Late-Stage Cancer Patients (Project No. 1050098; Guangzhou TCM [2005] No. 27).
2007
Directed Panyu District Science Bureau project: Integrative TCM-Western Medicine Mode/ for Mid-to-Late-Stage Colon Cancer,
(Project No. 2007-Z-69-1).
2008
Chief Editor: JCI International Hospital Standards: A Practical Guide for Chinese Hospitals (1780000 words, People's Medical Publishing House, Sep. 2008).
2008
Authored Green Comprehensive Therapy for Cancer (591000 words, China TCM Publishing House Oct.2008).
2011
Authored Green Comprehensive Therapy: A New Milestone in Cancer Prevention and Treatment (150000 words, Hong Kong Economic Times Press, 2011). 2013
Authored Hyperthermia for Cancer (462000 words, People's Medical Publishing House, Oct.2013).
2016
<Hyperthermia in Oncology> CRC Press.
Completed 9 Academic Papers:
2006
Green Comprehensive Therapy for Cancer: A New Milestone (Modern Hospitals, 2006, Vol.6 No.12) — Awarded "Outstanding Paper" by CMA Oncology Conference.
2007
"Green Comprehensive Therapy for Tumors" was included in the Abstracts of the Third World Congress on Integrative Medicine, September 2007.
2008
Quality Improvement System at Clifford Hospital. [J] Modern Hospitals, 2008, Issue 4.
2009
Research Progress in Hepatocarcinoma Therapeutics [J] Chinese Journal of Gerontology, 2009, Vol. 29, No.5.
2009
High-Dose Vitamin C Therapy for Implanted Hepatoma in Rats. [J] Journal of Southern Medical University, 2009, Vol.29 No.2).
2009
Experimental Study and Analysis of Fuzheng Kang'ai Formula on Transplanted Hepatocellular Carcinoma in Rats. China Journal of Traditional Chinese Medicine and Pharmacy, 2009, Vol. 24, No. 6.
2009
Study on Fuzheng Kang'ai Formula in Treating Transplanted Hepatocellular Carcinoma in Rats. [J] Chinese Journal of Pathophysiology, 2009, Vol. 25, No.4.
2009
Case Report: Green Comprehensive Therapy Combined with Surgery for Giant Mediastinal Fibrosarcoma — Awarded "Outstanding Paper" by CMA Oncology Conference.
2009
Clifford L.K.Pang, LU Daxiang, QI Renbin, ZHANG Tao, WANG Zhen, SUN Yong. Study on the use of Intravenous high-dose Vitamin c in the treatment of implanted hepatoma in rats [J]. ACNEM, 2009, Accepted.
